15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering CBIZ Inc, 2 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $31.00 to $60.00, a moderate spread. The average target of $42.25 sits 10% below the current $46.70. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.25 next quarter toward $4.50 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy250%
Hold250%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to CBIZ Inc.
As of Jul, 2 of 4 firms rate CBZ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CBZ EPS & revenue forecast
EPS · NEXT QUARTER
$1.25
Range $0.96 – $1.35 · 6 analysts · +24% YoY
Next period, 6 analysts expect CBIZ Inc to earn $1.25 a share (range $0.96 – $1.35), versus $1.01 a year earlier. Full-year consensus is $4.07, growing to $4.50 the year after.
REVENUE · NEXT QUARTER
$722.5M
Range $714.4M – $729.0M · 6 analysts · +4% YoY
Revenue is expected to reach $722.5M (range $714.4M – $729.0M), +4.1% year-over-year. Full-year consensus is $2.8B, rising to $3.0B next year.
Top analysts covering CBIZ Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CBZ.
#1
Jeffrey Silber
BMO Capital · Rank #269
Buy
$33.00-29.3% to target
Overall win rate
31%
+ Follow
#2
Vincent Colicchio
Barrington Research · Rank #324
Buy
$45.00-3.6% to target
Overall win rate
35%
+ Follow
#3
Faiza Alwy
Deutsche Bank
Hold
$42.00-10.1% to target
Coverage
—
+ Follow
#4
Andrew Nicholas
William Blair
Buy
$33.00-29.3% to target
Coverage
—
+ Follow
#5
TW
Thomas Wendler
Stephens & Co.
Hold
$31.00-33.6% to target
Coverage
—
+ Follow
CBZ stock forecast FAQ
What is CBZ's average 12-month price target?+
The 4 analysts with a live target average $42.25 for CBIZ Inc over the next 12 months, ranging from a $60.00 high to a $31.00 low.
Is CBZ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CBZ?+
The Street-high target is $60.00 (Deutsche Bank), and the Street-low is $31.00 (Stephens & Co.). The average of all 4 active targets is $42.25.
How many Wall Street analysts cover CBZ?+
4 analysts have an active rating on CBIZ Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering CBZ?+
Among analysts who currently cover CBZ, Jeffrey Silber of BMO Capital has the strongest overall Quantellect track record (Rank #269). Their current call is Buy with a $33.00 target.
What is CBIZ Inc's projected EPS for next quarter?+
The consensus estimate is $1.25 per share (range $0.96 – $1.35) across 6 analysts. Full-year EPS is projected at $4.07, rising to $4.50 the following year.
How much revenue is CBIZ Inc expected to report next quarter?+
Consensus revenue is $722.5M (range $714.4M – $729.0M). Full-year revenue is projected at $2.8B, growing to $3.0B next year.
Have analysts been upgrading or downgrading CBZ lately?+
As of Jul, 2 of 4 firms rate CBZ a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CBZ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
